|
MechanismFAAH2 inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
|
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
|
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Kadmus Pharmaceuticals, Inc.
0 Patents (Medical) associated with Kadmus Pharmaceuticals, Inc.
100 Deals associated with Kadmus Pharmaceuticals, Inc.
100 Translational Medicine associated with Kadmus Pharmaceuticals, Inc.